{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:31:37Z","timestamp":1791556297313,"version":"4.3.4"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.amjms.2018.11.007","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T04:02:19Z","timestamp":1542859339000},"page":"93-102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Sinonasal and Laryngeal Sarcoidosis\u2014An Uncommon Presentation and Management Challenge"],"prefix":"10.1016","volume":"357","author":[{"given":"Hawa","family":"Edriss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Demke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2018.11.007_bib0001","series-title":"Sarcoidosis and Other Granulomatous Disorders","first-page":"729","article-title":"Epidemiology","author":"James","year":"1994"},{"key":"10.1016\/j.amjms.2018.11.007_bib0002","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","article-title":"Sarcoidosis","volume":"336","author":"Newman","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2018.11.007_bib0003","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/oxfordjournals.aje.a114313","article-title":"The epidemiology of sarcoidosis in Rochester, Minnesota: a population based study of incidence and survival","volume":"123","author":"Henke","year":"1968","journal-title":"Am J Epid"},{"key":"10.1016\/j.amjms.2018.11.007_bib0004","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4081\/reumatismo.2017.965","article-title":"Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota","volume":"69","author":"Ungprasert","year":"2017","journal-title":"Reumatismo"},{"key":"10.1016\/j.amjms.2018.11.007_bib0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1513\/AnnalsATS.201508-568BC","article-title":"Epidemiology of sarcoidosis in a prospective cohort study of U.S. Women","volume":"13","author":"Dumas","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.amjms.2018.11.007_bib0006","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.disamonth.2009.04.008","article-title":"Epidemiology, etiology, pathogenesis, and genetics","volume":"55","author":"Sarcoidosis","year":"2009","journal-title":"Dis Mon"},{"key":"10.1016\/j.amjms.2018.11.007_bib0007","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/lary.5540841120","article-title":"Intranasal sarcoidosis","volume":"84","author":"Wright","year":"1974","journal-title":"Laryngoscope"},{"key":"10.1016\/j.amjms.2018.11.007_bib0008","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","article-title":"ACCESS research group. A case control etiologic study of sarcoidosis: environmental and occupational risk factors","volume":"170","author":"Newman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjms.2018.11.007_bib0009","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1086\/378097","article-title":"HLA-DRB1 1101: a significant risk factor for sarcoidosis in blacks and whites","volume":"73","author":"Rossman","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.amjms.2018.11.007_bib0010","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.chest.2017.11.030","article-title":"The pathogenesis of pulmonary sarcoidosis and implications for treatment","volume":"153","author":"Patterson","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.amjms.2018.11.007_bib0011","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1089\/jir.2006.26.400","article-title":"Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis","volume":"26","author":"Antoniou","year":"2006","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.amjms.2018.11.007_bib0012","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1089\/107999003322277865","article-title":"Characterization of p40 and IL-10 in the BALF of patients with pulmonary sarcoidosis","volume":"23","author":"Barbarin","year":"2003","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.amjms.2018.11.007_bib0013","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1172\/JCI111852","article-title":"Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis","volume":"75","author":"Robinson","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjms.2018.11.007_bib0014","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.1073\/pnas.78.11.7147","article-title":"Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases","volume":"78","author":"Rennard","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.amjms.2018.11.007_bib0015","first-page":"36","article-title":"Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis","volume":"115","author":"Baughman","year":"1990","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.amjms.2018.11.007_bib0016","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1164\/ajrccm.156.5.97-02050","article-title":"Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers","volume":"156","author":"Ziegenhagen","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"10 pt 1","key":"10.1016\/j.amjms.2018.11.007_bib0017","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjms.2018.11.007_bib0018","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.chest.2018.02.003","article-title":"Clinical features of extrapulmonary sarcoidosis without lung involvement","volume":"154","author":"James","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.amjms.2018.11.007_bib0019","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjms.2018.11.007_bib0020","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00405-010-1449-y","article-title":"Clinically isolated laryngeal sarcoidosis","volume":"268","author":"Plaschke","year":"2011","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.amjms.2018.11.007_bib0021","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/lary.1983.93.10.1281","article-title":"Sarcoidosis of the nose and paranasal sinuses","volume":"93","author":"McCaffrey","year":"1983","journal-title":"Laryngoscope"},{"key":"10.1016\/j.amjms.2018.11.007_bib0022","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2500\/105065800782102753","article-title":"Nasal and sinus manifestations of sarcoidosis","volume":"14","author":"Zeitlin","year":"2000","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.amjms.2018.11.007_bib0023","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/thx.31.6.660","article-title":"Sarcoidosis of the upper respiratory tract and its association with lupus pernio","volume":"31","author":"Neville","year":"1976","journal-title":"Thorax"},{"key":"10.1016\/j.amjms.2018.11.007_bib0024","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/SMJ.0b013e3181ebcda5","article-title":"Clinical manifestations, radiographic findings, treatment options, and outcome in sarcoidosis patients with upper respiratory tract involvement","volume":"103","author":"Panselinas","year":"2010","journal-title":"Southern Med J"},{"key":"10.1016\/j.amjms.2018.11.007_bib0025","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.otohns.2006.01.011","article-title":"Upper respiratory tract involvement of sarcoidosis in the Turkish population","volume":"134","author":"Yanardag","year":"2006","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.amjms.2018.11.007_bib0026","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/01.md.0000236955.79966.07","article-title":"Sinonasal involvement in sarcoidosis: a case-controlled study of 20 patients","volume":"85","author":"Aubart","year":"2006","journal-title":"Medicine"},{"key":"10.1016\/j.amjms.2018.11.007_bib0027","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2466-13-59","article-title":"Sarcoidosis with involvement of the paranasal sinuses \u2013 a retrospective analysis of 12 biopsy-proven cases","volume":"13","author":"Kirsten","year":"2013","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.amjms.2018.11.007_bib0028","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1097\/01.mlg.0000147928.06390.db","article-title":"Sinonasal sarcoidosis: review and report of fifteen cases","volume":"114","author":"Braun","year":"2004","journal-title":"Laryngoscope"},{"key":"10.1016\/j.amjms.2018.11.007_bib0029","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2500\/ajra.2014.28.4061","article-title":"Sinonasal sarcoidosis: a new system of classification acting as a guide to diagnosis and treatment","volume":"28","author":"Lawson","year":"2014","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.amjms.2018.11.007_bib0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/annrheumdis-2012-eular.2368","article-title":"Sinonasal sarcoidosis: review of clinical and imaging features: 7 year experience","volume":"71","author":"Joshi","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.amjms.2018.11.007_bib0031","doi-asserted-by":"crossref","first-page":"E27","DOI":"10.1177\/014556131209100420","article-title":"Intracranial sarcoid granuloma as an extension of severe sinonasal sarcoidosis","volume":"91","author":"Wold","year":"2012","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.amjms.2018.11.007_bib0032","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neurad.2009.09.001","article-title":"Imaging in sinonasal sarcoidosis: CT, MRI, 67gallium scintigraphy and 18F\u2013FDG PET\/CT features","volume":"37","author":"Braun","year":"2010","journal-title":"J Neuroradiol"},{"key":"10.1016\/j.amjms.2018.11.007_bib0033","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12105-016-0689-6","article-title":"Non-infectious inflammatory lesions of the sinonasal tract","volume":"10","author":"Helliwell","year":"2016","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.amjms.2018.11.007_bib0034","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/archotol.1940.00660020318007","article-title":"Sarcoidosis of the larynx","volume":"32","author":"Poe","year":"1949","journal-title":"Arch Otolaryngol"},{"key":"10.1016\/j.amjms.2018.11.007_bib0035","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/000348948209100406","article-title":"Laryngeal sarcoidosis: report of 13 patients","volume":"91","author":"Neel","year":"1982","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.amjms.2018.11.007_bib0036","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/000348949510400705","article-title":"Laryngoscopic diagnosis of laryngeal sarcoid","volume":"104","author":"Benjamin","year":"1995","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.amjms.2018.11.007_bib0037","first-page":"227","article-title":"Laryngeal sarcoidosis: a case-control study","volume":"31","author":"Duchemann","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.amjms.2018.11.007_bib0038","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0892-1997(99)80027-7","article-title":"Laryngeal sarcoidosis presenting as an isolated submucosal vocal fold mass","volume":"13","author":"McLaughlin","year":"1999","journal-title":"J Voice"},{"key":"10.1016\/j.amjms.2018.11.007_bib0039","first-page":"325","article-title":"Manifestations and treatment of laryngeal sarcoidosis","volume":"122","author":"Bower","year":"1980","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.amjms.2018.11.007_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-209728","article-title":"A rare manifestation of a multisystemic disease: a case of vocal cord palsy secondary to sarcoidosis","author":"Mastan","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.amjms.2018.11.007_bib0041","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/00007611-199306000-00006","article-title":"Acute upper airway obstruction resulting from systemic disease","volume":"86","author":"Lerner","year":"1993","journal-title":"South Med J"},{"key":"10.1016\/j.amjms.2018.11.007_bib0042","first-page":"201","article-title":"Nasal manifestations of systemic disease","author":"Jackson","year":"2014","journal-title":"Cummings Otolaryngology Head and Neck Surgery"},{"key":"10.1016\/j.amjms.2018.11.007_bib0043","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/000348941011901004","article-title":"Atypical and disparate presentations of laryngeal sarcoidosis","volume":"119","author":"Mayerhoff","year":"2010","journal-title":"Ann Otol Rhinol Otolaryngol"},{"key":"10.1016\/j.amjms.2018.11.007_bib0044","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/qjmed\/hcs042","article-title":"Oral involvement in sarcoidosis: report of 12 cases","volume":"105","author":"Bouaziz","year":"2012","journal-title":"QJ Med"},{"key":"10.1016\/j.amjms.2018.11.007_bib0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/archoto.2010.16","article-title":"Endoscopic airway management of laryngeal sarcoidosis","volume":"136","author":"Butler","year":"2010","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.amjms.2018.11.007_bib0046","series-title":"Chapter 2. Diseases of the Central Airways: A Clinical Guide","first-page":"71","article-title":"Sarcoidosis of the upper and lower airways diseases of the Q5 central airways","author":"DA","year":"2016"},{"key":"10.1016\/j.amjms.2018.11.007_bib0047","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/rcr2.118","article-title":"Spontaneous improvement of laryngeal sarcoidosis resistant to systemic corticosteroid administration","volume":"3","author":"Tsubouchi","year":"2015","journal-title":"Respirol Case Rep"},{"key":"10.1016\/j.amjms.2018.11.007_bib0048","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1080\/14656566.2016.1258061","article-title":"SarcoGEAS-SEMI study group. Sarcoidosis: an update on current pharmacotherapy options and future directions","volume":"17","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.amjms.2018.11.007_bib0049","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1365-2249.1997.d01-979.x","article-title":"Corticosteroids restore the balance between locally produced Th1 and Th2 cytokines and immunoglobulin isotypes to normal in sarcoid lung","volume":"108","author":"Milburn","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.amjms.2018.11.007_bib0050","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/0003-4819-95-4-464","article-title":"Beclomethasone dipropionate","volume":"95","author":"Williams","year":"1981","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjms.2018.11.007_bib0051","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2796.1994.tb00798.x","article-title":"No effect of high-dose inhaled steroids in pulmonary sarcoidosis: a double-blind, placebo-controlled study","volume":"236","author":"Milman","year":"1994","journal-title":"J Intern Med"},{"key":"10.1016\/j.amjms.2018.11.007_bib0052","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1183\/09031936.99.13613519","article-title":"Randomized trial of inhaled fluticasone propionate in chronic stable pulmonary sarcoidosis: a pilot study","volume":"13","author":"du Bois","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjms.2018.11.007_bib0053","first-page":"A495","article-title":"Efficacy, safety and tolerability of 3M HFA-134a beclomethasone dipropionate in pulmonary sarcoidosis","volume":"165","author":"McGrath","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjms.2018.11.007_bib0054","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/pgmj.67.786.327","article-title":"Inhaled corticosteroids in pulmonary sarcoidosis","volume":"67","author":"Spiteri","year":"1991","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.amjms.2018.11.007_bib0055","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1749-6632.1986.tb18550.x","article-title":"Use of budesonide in the treatment of pulmonary sarcoidosis","volume":"465","author":"Selroos","year":"1986","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.amjms.2018.11.007_bib0056","first-page":"429","article-title":"Characterization of immune inducer and suppressor macrophages from the normal human lung","volume":"83","author":"Spiteri","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.amjms.2018.11.007_bib0057","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1183\/09031936.95.08050682","article-title":"Inhaled budesonide in pulmonary sarcoidosis: a double-blind, placebo-controlled study. Dutch Study Group on Pulmonary Sarcoidosis","volume":"8","author":"Alberts","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjms.2018.11.007_bib0058","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1378\/chest.116.2.424","article-title":"Oral prednisolone followed by inhaled budesonide in newly diagnosed pulmonary sarcoidosis: a double-blind, placebo-controlled multicenter study. Finish pulmonary sarcoidosis study group","volume":"116","author":"Pietinalho","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.amjms.2018.11.007_bib0059","first-page":"56","article-title":"Inhaled budesonide vs prednisone in the maintenance treatment of pulmonary sarcoidosis","volume":"10","author":"Zych","year":"1993","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.amjms.2018.11.007_bib0060","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/thx.54.8.742","article-title":"A clinical approach to the use of methotrexate for sarcoidosis","volume":"54","author":"Baughman","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/j.amjms.2018.11.007_bib0061","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/pgmj.74.869.172","article-title":"Sarcoidosis of the paranasal sinuses treated with hydroxychloroquine","volume":"74","author":"Hassid","year":"1998","journal-title":"Postgrad Medical J"},{"issue":"5 pt 2","key":"10.1016\/j.amjms.2018.11.007_bib0062","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0190-9622(98)70360-3","article-title":"Disfiguring cutaneous manifestation of sarcoidosis treated with thalidomide: a case report","volume":"39","author":"Lee","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjms.2018.11.007_bib0063","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1378\/chest.122.1.227","article-title":"Thalidomide for chronic sarcoidosis","volume":"122","author":"Baughman","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.amjms.2018.11.007_bib0064","first-page":"76","article-title":"Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them","volume":"25","author":"Baughman","year":"2008","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.amjms.2018.11.007_bib0065","first-page":"185","article-title":"Exaggerated TNF\u03b1 release of alveolar macrophages in corticosteroid resistant sarcoidosis","volume":"19","author":"Ziegenhagen","year":"2002","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.amjms.2018.11.007_bib0066","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jaad.2012.10.056","article-title":"A double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis","volume":"68","author":"Pariser","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.amjms.2018.11.007_bib0067","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1183\/09031936.00051907","article-title":"Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial","volume":"31","author":"Judson","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjms.2018.11.007_bib0068","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.amjms.2018.11.007_bib0069","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1183\/09031936.00000914","article-title":"Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis","volume":"44","author":"Judson","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjms.2018.11.007_bib0070","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1128\/CVI.00337-10","article-title":"Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis","volume":"18","author":"Loza","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.amjms.2018.11.007_bib0071","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1378\/chest.08-1347","article-title":"The treatment of lupus pernio: results of 116 treatment courses in 54 patients","volume":"135","author":"Stagaki","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.amjms.2018.11.007_bib0072","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/jamadermatol.2017.1162","article-title":"Efficacy and tolerance of anti-tumor necrosis factor \u03b1 agents in cutaneous sarcoidosis: a French study of 46 cases","volume":"153","author":"Heidelberger","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.amjms.2018.11.007_bib0073","doi-asserted-by":"crossref","first-page":"E904","DOI":"10.1097\/BRS.0b013e3181dc9a54","article-title":"Osseous sarcoidosis treated with tumor necrosis factor-inhibitors: case report and review of the literature","volume":"35","author":"Hasni","year":"2010","journal-title":"Spine"},{"key":"10.1016\/j.amjms.2018.11.007_bib0074","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1183\/09031936.00169413","article-title":"Association of the TNF-G-308A polymorphism with TNF-inhibitor response in sarcoidosis","volume":"43","author":"Wijnen","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjms.2018.11.007_bib0075","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/000348948709600622","article-title":"Treatment of laryngeal sarcoidosis with intralesional steroid injection","volume":"96","author":"Krespi","year":"1987","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.amjms.2018.11.007_bib0076","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0892-1997(02)00099-1","article-title":"Laryngeal sarcoidosis","volume":"16","author":"Dean","year":"2002","journal-title":"J Voice"},{"key":"10.1016\/j.amjms.2018.11.007_bib0077","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1378\/chest.65.6.693","article-title":"Sarcoidosis of the larynx causing airway obstruction","volume":"65","author":"Carasso","year":"1974","journal-title":"Chest"},{"key":"10.1016\/j.amjms.2018.11.007_bib0078","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0194-5998(98)70282-7","article-title":"Surgical management of nasal and sinus sarcoidosis","volume":"118","author":"Marks","year":"1998","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.amjms.2018.11.007_bib0079","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/194589240101500406","article-title":"The role of endoscopic sinus surgery in chronic sinonasal sarcoidosis","volume":"15","author":"Kay","year":"2001","journal-title":"Am J Rhinol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296291830421X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000296291830421X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:35:50Z","timestamp":1757702150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000296291830421X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S000296291830421X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2018.11.007","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sinonasal and Laryngeal Sarcoidosis\u2014An Uncommon Presentation and Management Challenge","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2018.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}